Impax Laboratories Inc (NASDAQ:IPXL)

20.50
Delayed Data
As of Feb 22
 +0.10 / +0.49%
Today’s Change
7.75
Today|||52-Week Range
25.70
+23.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line101.3M57.4M39.0M-472.0M
 
 
 
 
 
Depreciation36.0M34.0M68.6M88.3M
 
 
 
 
 
Total Other Cash Flow44.9M29.5M64.0M588.1M
 
 
 
 
 
Funds From Operations161.0M109.0M142.1M77.0M
 
 
 
 
 
Funds From/For Other Operating Expenses11.0M76.2M70.2M2.4M
 
 
 
 
 
Net Cash Flow - Operating Activities149.9M32.8M71.9M74.6M
 
 
 
 
 
 
InvestingIncrease In Investments-357.1M-366.1M0.000.00
 
 
 
Decrease In Investments286.0M395.4M200.1M0.00
 
 
 
 
Capital Expenditures-32.8M-29.9M-25.2M-49.4M
 
 
 
 
 
Fixed Asset Disposal----59.5M1.4M
 
 
 
Net Assets From Acquisitions 0.00---691.3M-585.8M
 
 
 
Other Investing - Uses0.00-3.0M-4.8M-4.8M
 
 
 
 
Other Investing - Sources------15.0M
 
 
Net Cash Flow Investing-115.9M-16.6M-467.5M-627.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.00998.1M388.1M
 
 
 
Long Term Debt Reduction0.000.00-435.0M-5.0M
 
 
 
Net Proceeds Stock Sale8.2M11.1M99.8M9.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.00------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing749.0K3.3M5.5M--
 
 
 
 
Other Uses - Financing----147.0M589.0K
 
 
 
Net Cash Flow - Financing9.0M14.4M521.4M391.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-561.0K-369.0K-298.0K494.0K
 
 
 
 
 
 
Net Change In Cash43.0M30.6M125.8M-160.7M